Big Ideas Are Born Here
What’s a big idea? In the world of health care and biomedical research, big ideas are discoveries that fundamentally transform what is possible. They jumpstart new thinking and ignite new hope.
At Oregon Health & Science University, big ideas come in all shapes and sizes, but the biggest and best have one thing in common—they change the world for patients and families. Here are a few that make us proud:
A pill that stops cancer
OHSU’s Lasker Award winning Brian Druker, M.D., director of the OHSU Knight Cancer Institute, led the development of Gleevec, a pill that stops chronic myeloid leukemia and other cancers by turning off the molecular switch that drives its spread.
Watch a video highlighting the work of Dr. Druker and his colleagues in the OHSU Knight Cancer Institute.
A valve that heals hearts
Lasker winner and pioneering cardiac surgeon Albert Starr, M.D., co-invented and implanted the world’s first successful artificial heart valve at OHSU, transforming the treatment of valve disease and giving rise to a vibrant sector in the medical device industry.
A theory that reveals the true origins of chronic disease
OHSU’s David Barker, M.D., Ph.D., pioneered the study of the fetal/developmental origins of chronic adult diseases such as type 2 diabetes and heart disease. Although he is now deceased, his work with OHSU’s Kent Thornburg, Ph.D., is leading to new interventions and preventive strategies to promote good nutrition in future mothers. OHSU’s Bob & Charlee Moore Institute for Nutrition & Wellness is translating that knowledge into programs and public policies that will change the game against childhood obesity and its devastating complications.Watch the video
A translator for the complex language of brain cells
By developing powerful new ways to characterize the structure and function of the synapse, National Academy of Sciences member Eric Gouaux, Ph.D., of OHSU’s Vollum Institute, is decoding the signals that nerve cells use to communicate. It will reveal the way our brains work, and expose new targets for better drugs.
A four-dimensional approach to studying diseased cells
Renowned Knight Cancer Institute researcher Joe W. Gray, Ph.D., OHSU’s Gordon Moore Chair in Biomedical Engineering, is pioneering an entirely new field of cancer biology: spatial systems biomedicine. He is using unique tools, including the world’s first integrated light and electron microscope for bioimaging, to collect structural and genomic information on healthy and diseased cells in the three dimensions of physical space and also over time. It’s a key step in the development of personalized cancer medicine at OHSU and everywhere else.
A smarter path to an AIDS vaccine
Gene therapies that could stop the leading causes of permanent blindness
Researchers at the OHSU Casey Eye Institute are conducting some of the world’s first clinical trials on gene therapies that may prevent blindness due to abnormal growth of new blood vessels in the eye. Trials are now under way of promising therapies for a form of macular degeneration and other blinding diseases.
A genetic key to new autism drugs
Gail Mandel, Ph.D., a National Academy of Sciences member and Vollum Institute senior scientist, showed that Rett Syndrome, a devastating autism-spectrum disorder that strikes young girls, is a complex disorder due to glia and neurons. She is exploring several promising gene therapy approaches toward a cure.
A new source of stem cells
OHSU’s Shoukhrat Mitalipov, Ph.D., was the first to report the use of skin cells from a non-human primate to create pluripotent stem cells. This work could lead to better experimental disease models in the lab, new cures for devastating human diseases, and an answer to the debate over embryonic stem cells.
Watch a video of Dr. Mitalipov discussing his research.
Technologies that keep seniors safe
Neuroscientists, engineers and physicians across OHSU are developing the next generation of sensing, monitoring and assistive devices that help elderly people live more safely and independently.
Watch an NBC story on the technology being developed at OHSU.
Imaging techniques that get to the heart of disease
More than 50 years after OHSU radiologists performed the world’s first angioplasty, OHSU is still at the forefront of transforming medical imaging methods into active cardiovascular treatments. Sanjiv Kaul, M.D., and Jonathan Lindner, M.D., are combining intravenous microbubbles with molecular targeting for early diagnosis of disease, breaking up blood clots and to deliver drugs and genes to precise anatomical sites.
Without exception, big ideas like these have been advanced by breakthrough collaborations among passionate physicians and scientists—and through powerful partnerships with private industry, government leaders, and donors of all types. Partnerships make big ideas better. They bring big ideas to life for all of us—for all time.